Skip to main content
. 2017 Mar 22;7:44792. doi: 10.1038/srep44792

Table 2. Statistically significant metabolite levels of all histologies between IDH status and tumor grade.

  All histologies (med ± SE)   All histologies (med ± SE)
Metabolite IDH-mut IDH-wt Grade II Grade III GBM
Cho Cho 7.4 ± 1.26 3.72 ± 0.73
GPC 20.2 ± 3.64 9.2 ± 2.09
PC 11.54 ± 3.0 6.58 ± 1.37 9.38 ± 1.68 14.26 ± 5.04 26.44 ± 15.08
tCho 38.18 ± 5.81 21.03 ± 3.16 23.05 ± 5.01 36.31 ± 9.37 64.27 ± 18.48
GSH 11.52 ± 1.54 12.76 ± 4.51 17.28 ± 7.06
hTau 2.05 ± 0.63 4.07 ± 0.77
Tau 14.87 ± 2.3 31 ± 4.24 29.6 ± 10.1
2HG 8.17 ± 1.01 2.82 ± 0.47 5.43 ± 1.1 7.88 ± 1.57 13.7 ± 2.57
Glu 49.84 ± 4.99 94.18 ± 33.03 41.76 ± 6.17 52.18 ± 8.13 79.79 ± 24.65
Gln 33.09 ± 5.64 38.24 ± 15.39
Glc 31.31 ± 5.12 35.74 ± 44.41
Ala 11.73 ± 2.31 17.12 ± 9.49 20.87 ± 10.88
Asp 37.83 ± 4.89 39.33 ± 5.83 71.32 ± 27.7
GABA 2.92 ± 0.42 6.48 ± 3.04
Gly 33.46 ± 5.67 46.12 ± 8.57 78.03 ± 29.75
Bet 0.85 ± 0.1 0.88 ± 0.18 1.27 ± 0.6

Mixed-effects logistical regression results demonstrated significant differences in various metabolite levels between IDH genotype and tumor grades (p < 0.05). Metabolite levels are presented for statistically significant metabolites at a tissue sample level. These results are presented as median spectral areas for each metabolite as fit by HR-QUEST.